Catalyst Wire Dossier Catalyst Wire Dossier

TALVEY

talquetamab · Janssen Biotech, Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for TALVEY, covering 2023-08-09 to 2026-03-05. Get the full timeline:

Most recent: FDA Approved: TALVEY — Supplemental Application (Janssen Biotech, Inc.)

See pricing